Serum lipoprotein (a) concentration in patients with nephrotic syndrome and its clinical implication
- 17 Downloads
Serum lipoprotein (a) [Lp(a)] concentration was determined in 42 patients with primary nephrotic syndrome (NS) and the relationships between Lp (a) and plasma lipids, apolipoproteins, serum creatinine (Scr), albumin, urinary proteins (Upro) were also analyzed. The results showed that: (1) serum Lp(a) concentrations in the patients with NS were higher than those in healthy controls; (2) the levels of serum Lp(a) were correlated positively with total cholesterol (TO, low density lipoprotein cholesterol (LDL-C), very low density lipoprotein cholesterol (VLDL-C), apolipoprotein B (Apo-B), Upros (Upro). It is concluded that the NS patients had the potential risk of suffering from coronary artery disease, glomerular sclerosis and thrombosis. The remission of NS may partially decrease the serum Lp(a) levels. Further studies are needed to explore the prevention and treatment of dislipedemia in patients with NS.
Key wordslipoprotein (a) nephrotic syndrome dislipedemia
Unable to display preview. Download preview PDF.
- 1.Ordonez J D, Robert H, Ellen Ket al. The risk of coronary artery disease among patients with the nephrotic syndrome. Kidney Int, 1990, 37: 243Google Scholar
- 3.Appel G B, Blum C B, Chien Set al. The hyperlipidemia of the nephrotic syndrome, relation to plasma albumin concentration, oncotic pressure, and viscosity. N Eng J Med, 1985, 312: 1544Google Scholar
- 4.Steinberg D, Parthasarphy S, Carew T Eet al. Beyond cholesterol modification of low density lipoprotein that increase its atherogenity. N Engl JMed, 1989, 320:915Google Scholar
- 10.Wanner C, Rader D, Barten Wet al. Elevated plasma Lp(a) in patients with the nephrotic syndrome. Ann Inter Med, 1993, 119:263Google Scholar